Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NUC.L Stock Summary
In the News
NUC.L Financial details
Company Rating
Strong Buy
Market Cap
0
Income
5.65M
Revenue
50.99M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
356
Optionable
No
Shortable
Yes
Earnings
06 Sep 2021
P/E
4571.3
Forward P/E
-
PEG
-10187.47
P/S
-
P/B
639.11
P/C
-
P/FCF
-
Quick Ratio
1.77
Current Ratio
2.88
Debt / Equity
0.16
LT Debt / Equity
0.14
-
-
EPS (TTM)
0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-46.28%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.11%
Revenue last 5Y
9.26%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
9%
ROE
15%
ROC
0.16%
Gross Margin
55%
Oper. Margin
8%
Profit Margin
6%
Payout
24%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
193-193
52W High
-0.78%
52W Low
-0.78%
RSI
75
Rel Volume
0.02
Avg Volume
787
Volume
17
Perf Week
0%
Perf Month
0%
Perf Quarter
0%
Perf Half Y
3.51%
-
-
-
-
Beta
1.38664
-
-
Volatility
0%, 0%
Prev Close
0%
Price
191.5
Change
-
NUC.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2020-12-31
Metric | History | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.44 | 0.53 | 0.65 | 0.68 | 0.68 | |
Net income per share | 0.04 | 0.05 | 0.06 | 0.08 | 0.04 | |
Operating cash flow per share | 0.02 | 0.13 | 0.07 | 0.08 | 0.04 | |
Free cash flow per share | 0.01 | 0.11 | 0.06 | 0.07 | 0.03 | |
Cash per share | 0.18 | 0.22 | 0.23 | 0.24 | 0.23 | |
Book value per share | 0.21 | 0.21 | 0.23 | 0.26 | 0.3 | |
Tangible book value per share | 0.21 | 0.21 | 0.23 | 0.26 | 0.27 | |
Share holders equity per share | 0.21 | 0.21 | 0.23 | 0.26 | 0.3 | |
Interest debt per share | 0 | 0 | 0 | 0.06 | 0.05 | |
Market cap | 146.45M | 146.45M | 145.44M | 146.07M | 145.28M | |
Enterprise value | 132.71M | 129.65M | 127.86M | 131.76M | 131.47M | |
P/E ratio | 43.24 | 35.62 | 30.58 | 24.54 | 45.71 | |
Price to sales ratio | 4.4 | 3.63 | 2.94 | 2.84 | 2.8 | |
POCF ratio | 101.28 | 15.3 | 26.52 | 24.29 | 48.12 | |
PFCF ratio | 147.63 | 17.87 | 31.27 | 26.98 | 68.2 | |
P/B Ratio | 9.04 | 9.05 | 8.32 | 7.41 | 6.39 | |
PTB ratio | 9.04 | 9.05 | 8.32 | 7.41 | 6.39 | |
EV to sales | 3.99 | 3.21 | 2.59 | 2.56 | 2.54 | |
Enterprise value over EBITDA | 28.91 | 23.42 | 20.47 | 15.9 | 25.08 | |
EV to operating cash flow | 91.78 | 13.55 | 23.32 | 21.91 | 43.55 | |
EV to free cash flow | 133.78 | 15.82 | 27.49 | 24.34 | 61.72 | |
Earnings yield | 0.02 | 0.03 | 0.03 | 0.04 | 0.02 | |
Free cash flow yield | 0.01 | 0.06 | 0.03 | 0.04 | 0.01 | |
Debt to equity | 0.01 | 0.01 | 0.01 | 0.21 | 0.16 | |
Debt to assets | 0 | 0.01 | 0 | 0.12 | 0.1 | |
Net debt to EBITDA | -2.99 | -3.03 | -2.81 | -1.73 | -2.63 | |
Current ratio | 2.75 | 2.15 | 2.13 | 2.62 | 2.88 | |
Interest coverage | 0 | 1.71K | 808.57 | 39.47 | 24.99 | |
Income quality | 0.43 | 2.33 | 1.15 | 1.01 | 0.95 | |
Dividend Yield | 0 | 0.03 | 0.03 | 0.03 | 0.01 | |
Payout ratio | 0 | 1.17 | 0.83 | 0.65 | 0.24 | |
Sales general and administrative to revenue | 0.52 | 0.52 | 0.49 | 0.42 | 0.47 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0.01 | 0.06 | |
Capex to operating cash flow | -0.31 | -0.14 | -0.15 | -0.1 | -0.29 | |
Capex to revenue | -0.01 | -0.03 | -0.02 | -0.01 | -0.02 | |
Capex to depreciation | -1.73 | -3.35 | -1.42 | -0.55 | -0.85 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham number | 0.46 | 0.51 | 0.57 | 0.67 | 0.53 | |
ROIC | 0.21 | 0.25 | 0.27 | 0.22 | 0.11 | |
Return on tangible assets | 0.14 | 0.14 | 0.15 | 0.17 | 0.09 | |
Graham Net | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | |
Working capital | 15.12M | 14.38M | 15.36M | 18.03M | 18.87M | |
Tangible asset value | 16.19M | 16.18M | 17.47M | 19.45M | 20.47M | |
Net current asset value | 15.02M | 14.24M | 15.28M | 14.17M | 15.27M | |
Invested capital | 0.01 | 0.01 | 0.01 | 0.21 | 0.16 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 3.38M | 3.79M | 4.22M | 2.55M | 1.67M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 87.64 | 120.04 | 67.7 | 22.76 | 29.98 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 4.16 | 3.04 | 5.39 | 16.03 | 12.18 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.21 | 0.25 | 0.27 | 0.3 | 0.14 | |
Capex per share | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2020-12-31 for Q4
Metric | History | 2019-03-31 | 2019-06-30 | 2019-12-31 | 2020-06-30 | 2020-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.17 | 0.17 | 0 | 0 | 0 | |
Net income per share | 0.02 | 0.02 | 0 | 0 | 0 | |
Operating cash flow per share | 0.02 | 0.02 | 0 | 0 | 0 | |
Free cash flow per share | 0.02 | 0.02 | 0 | 0 | 0 | |
Cash per share | 0 | 0.23 | 0 | 0 | 0 | |
Book value per share | 0 | 0.24 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0.24 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0.24 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0.06 | 0 | 0 | 0 | |
Market cap | 145.28M | 145.28M | 0 | 0 | 0 | |
Enterprise value | 0 | 132.71M | -14.31M | -14.73M | -13.81M | |
P/E ratio | 24.4 | 24.4 | 0 | 0 | 0 | |
Price to sales ratio | 11.28 | 11.28 | 0 | 0 | 0 | |
POCF ratio | 96.61 | 96.61 | 0 | 0 | 0 | |
PFCF ratio | 107.33 | 107.33 | 0 | 0 | 0 | |
P/B Ratio | 0 | 8.04 | 0 | 0 | 0 | |
PTB ratio | 0 | 8.04 | 0 | 0 | 0 | |
EV to sales | 0 | 10.3 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 64.06 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 88.25 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 98.05 | 0 | 0 | 0 | |
Earnings yield | 0.01 | 0.01 | 0 | 0 | 0 | |
Free cash flow yield | 0.01 | 0.01 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.25 | 0.21 | 0.19 | 0.16 | |
Debt to assets | 0 | 0.14 | 0.12 | 0.12 | 0.1 | |
Net debt to EBITDA | 0 | -6.07 | 0 | 0 | 0 | |
Current ratio | 0 | 2.55 | 2.62 | 3.03 | 2.88 | |
Interest coverage | 39.47 | 39.47 | 0 | 0 | 0 | |
Income quality | 1.01 | 1.01 | 0 | 0 | 0 | |
Dividend Yield | 0.01 | 0.01 | 0 | 0 | 0 | |
Payout ratio | 0.65 | 0.65 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.42 | 0.42 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0.01 | 0 | 0.06 | |
Capex to operating cash flow | -0.1 | -0.1 | 0 | 0 | 0 | |
Capex to revenue | -0.01 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | -0.55 | -0.55 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0 | 0 | 0 | |
Graham number | 0 | 0.32 | 0 | 0 | 0 | |
ROIC | 0 | 0.06 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0.05 | 0 | 0 | 0 | |
Graham Net | 0 | 0.03 | 0 | 0 | 0 | |
Working capital | 0 | 16.46M | 18.03M | 19.57M | 18.87M | |
Tangible asset value | 0 | 18.06M | 19.45M | 21.14M | 20.47M | |
Net current asset value | 0 | 12.39M | 14.17M | 15.92M | 15.27M | |
Invested capital | 0 | 0.25 | 0.21 | 0.19 | 0.16 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 134.74 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0.67 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0.08 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
NUC.L Frequently Asked Questions
What is Nucleus Financial Group plc stock symbol ?
Nucleus Financial Group plc is a GB stock and trading under the symbol NUC.L
What is Nucleus Financial Group plc stock quote today ?
Nucleus Financial Group plc stock price is $191.5 today.
Is Nucleus Financial Group plc stock public?
Yes, Nucleus Financial Group plc is a publicly traded company.